248 related articles for article (PubMed ID: 30465158)
1. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
Dibaba DT; Ogunsina K; Braithwaite D; Akinyemiju T
Breast Cancer Res Treat; 2019 Feb; 174(1):209-218. PubMed ID: 30465158
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI.
Dibaba DT; Braithwaite D; Akinyemiju T
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30200454
[TBL] [Abstract][Full Text] [Related]
3. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
4. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract][Full Text] [Related]
5. Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort.
Reeves KW; McLaughlin V; Fredman L; Ensrud K; Cauley JA
Cancer Causes Control; 2012 Aug; 23(8):1241-51. PubMed ID: 22661101
[TBL] [Abstract][Full Text] [Related]
6. Changes in metabolic syndrome and the risk of breast and endometrial cancer according to menopause in Korean women.
Tran TXM; Kim S; Park B
Epidemiol Health; 2023; 45():e2023049. PubMed ID: 37139668
[TBL] [Abstract][Full Text] [Related]
7. Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients.
Crispo A; Augustin LSA; Luongo A; Calderaio C; Breda J; Coluccia S; Calabrese A; Marrazzo V; Giannatiempo R; Trasacco P; Palumbo E; Vitale S; Porciello G; Di Gennaro P; Caputo R; Buono G; Vernieri C; Schettini F; Grimaldi M; Nocerino F; Celentano E; Amore A; Giuliano M; De Placido P; De Angelis C; Bianco R; De Laurentiis M; La Vecchia C; Arpino G
Sci Rep; 2023 Dec; 13(1):21208. PubMed ID: 38040773
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
[No Abstract] [Full Text] [Related]
9. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
10. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
11. Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.
Bao PP; Zheng Y; Nechuta S; Gu K; Cai H; Peng P; Shu XO; Lu W
Cancer Causes Control; 2013 Sep; 24(9):1747-56. PubMed ID: 23860950
[TBL] [Abstract][Full Text] [Related]
12. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
Arthur RS; Kabat GC; Kim MY; Wild RA; Shadyab AH; Wactawski-Wende J; Ho GYF; Reeves KW; Kuller LH; Luo J; Beebe-Dimmer J; Simon MS; Strickler H; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2019 Apr; 30(4):355-363. PubMed ID: 30788634
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and all-cause mortality in older men and women.
Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
[TBL] [Abstract][Full Text] [Related]
15. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
Niraula S; Ocana A; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
[TBL] [Abstract][Full Text] [Related]
16. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S; Tsilidis KK; Dossus L; Rinaldi S; Weiderpass E; Antoniussen CS; Dahm CC; Tjønneland A; Mellemkjær L; Katzke V; Kaaks R; Schulze MB; Masala G; Grioni S; Panico S; Tumino R; Sacerdote C; May AM; Monninkhof EM; Quirós JR; Bonet C; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Rosendahl AH; Stocks T; Perez-Cornago A; Tin Tin S; Heath AK; Aglago EK; Peruchet-Noray L; Freisling H; Riboli E
BMC Cancer; 2023 Jun; 23(1):562. PubMed ID: 37337133
[TBL] [Abstract][Full Text] [Related]
17. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and breast cancer risk: a case-cohort study nested in a multicentre italian cohort.
Agnoli C; Grioni S; Sieri S; Sacerdote C; Ricceri F; Tumino R; Frasca G; Pala V; Mattiello A; Chiodini P; Iacoviello L; De Curtis A; Panico S; Krogh V
PLoS One; 2015; 10(6):e0128891. PubMed ID: 26030767
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, metabolic components, and their relation to the risk of pancreatic cancer.
Park SK; Oh CM; Kim MH; Ha E; Choi YS; Ryoo JH
Cancer; 2020 Jan; 126(9):1979-1986. PubMed ID: 32012239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
